Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal, Science Advances, March 2019, American Association for the Advancement of Science,
DOI: 10.1126/sciadv.aav6322.
You can read the full text:
Contributors
The following have contributed to this page
